Europe Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

Publisher Name :
Date: 18-Jan-2020
No. of pages: 111

Europe human insulin market accounted for $7.61 billion in 2019 and will grow by 7.06% annually over forecast years.

Highlighted with 37 tables and 56 figures, this 111-page report "Europe Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire Europe human insulin market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with estimates and forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

- Market Structure

- Growth Drivers

- Restraints and Challenges

- Emerging Product Trends & Market Opportunities

- Porter's Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Europe human insulin market in every aspect of the classification from perspectives of Product Type, Application, Distribution Channel, and Country.

Based on product type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Human Insulin Drugs

- Human Insulin Delivery Devices

Based on product, the Europe Human Insulin Drugs market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Modern Human Insulin (further segmented into Long-acting, Rapid- acting, Premixed by type; further segmented into Lantus, Apidra, Levemir, NovoRapid/ NovoLog, Novomix, Humalog, Others by brand)

- Traditional Human Insulin (further segmented into Short-acting, Intermediate & Rapid-acting, Premixed by type; further segmented into Humulin, Insuman, Novolin/Actrapid/Insulatard by brand)

Based on product, the Europe Human Insulin Delivery Devices market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Syringes

- Pens (further segmented into Disposable, Reusable, Pen needles)

- Pumps

- Others

Based on application, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Type 1 Diabetes

- Type 2 Diabetes

- Gestational Diabetes and Prediabetes

Based on distribution channel, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Geographically, the following national/local markets are fully investigated:

- Germany

- UK

- France

- Spain

- Italy

- Rest of Europe (further segmented into Russia, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)

For each of the aforementioned countries, market analysis and revenue data are available for 2019-2026. The breakdown of major national markets by Product Type, Application, and Distribution Channel over the study years (2019-2026) is included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Europe human insulin market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players:

Astra Zeneca PLC

Biocon

Eli Lilly

Exir

Julphar

Novo Nordisk AS

Pfizer

Sanofi Aventis

Sedico

Wockhardt

(Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Europe Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

Table of Contents
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.2 Major Growth Drivers 18
2.3 Market Restraints and Challenges 21
2.4 Emerging Opportunities and Market Trends 24
2.5 Porter's Fiver Forces Analysis 27
3 Segmentation of Europe Market by Product Type 31
3.1 Market Overview by Product Type 31
3.2 Human Insulin Drugs 33
3.3 Human Insulin Delivery Devices 34
4 Segmentation of Europe Human Insulin Drugs Market by Drug Product 35
4.1 Market Overview by Drug Product 35
4.2 Modern Human Insulin 37
4.2.1 Modern Human Insulin by Type 39
4.2.2 Modern Human Insulin by Brand 42
4.3 Traditional Human Insulin 49
4.3.1 Traditional Human Insulin by Type 51
4.3.2 Traditional Human Insulin by Brand 54
5 Segmentation of Europe Human Insulin Delivery Devices Market by Device Product 57
5.1 Market Overview by Product 57
5.2 Syringes 59
5.3 Pens 60
5.4 Pumps 61
5.5 Other Devices 62
6 Segmentation of Europe Market by Application 63
6.1 Market Overview by Application 63
6.2 Type 1 Diabetes 65
6.3 Type 2 Diabetes 66
6.4 Gestational Diabetes and Prediabetes 67
7 Segmentation of Europe Market by Distribution Channel 68
7.1 Market Overview by Distribution Channel 68
7.2 Hospital Pharmacies 70
7.3 Retail Pharmacies 71
7.4 Online Pharmacies 72
8 European Market 2019-2026 by Country 73
8.1 Overview of European Market 73
8.2 Germany 76
8.3 UK 78
8.4 France 80
8.5 Spain 82
8.6 Italy 84
8.7 Rest of European Market 86
9 Competitive Landscape 88
9.1 Overview of Key Vendors 88
9.2 New Product Launch, Partnership, Investment, and M&A 92
9.3 Company Profiles 94
Astra Zeneca PLC 94
Biocon 96
Eli Lilly 97
Exir 98
Julphar 99
Novo Nordisk AS 100
Pfizer 101
Sanofi Aventis 102
Sedico 103
Wockhardt 104
10 Investing in Europe Market: Risk Assessment and Management 105
10.1 Risk Evaluation of Europe Market 105
10.2 Critical Success Factors (CSFs) 108
Related Reports and Products 111

List of Tables

Table 1. Snapshot of Europe Human Insulin Market, 2019-2026 16
Table 2. Main Product Trends and Market Opportunities in Europe Human Insulin Market 24
Table 3. Europe Human Insulin Market by Product Type, 2019-2026, $ mn 31
Table 4. Europe Human Insulin Drugs Market by Product, 2019-2026, $ mn 35
Table 5. Europe Human Insulin Drugs Market: Modern Human Insulin by Type, 2019-2026, $ mn 38
Table 6. Europe Human Insulin Drugs Market: Modern Human Insulin by Brand, 2019-2026, $ mn 38
Table 7. Europe Human Insulin Drugs Market: Traditional Human Insulin by Type, 2019-2026, $ mn 50
Table 8. Europe Human Insulin Drugs Market: Traditional Human Insulin by Brand, 2019-2026, $ mn 50
Table 9. Europe Human Insulin Delivery Devices Market by Product, 2019-2026, $ mn 57
Table 10. Europe Human Insulin Delivery Devices Market: Pens by Product, 2019-2026, $ mn 60
Table 11. Europe Human Insulin Market by Application, 2019-2026, $ mn 63
Table 12. Europe Human Insulin Market by Distribution Channel, 2019-2026, $ mn 68
Table 13. Europe Human Insulin Market by Country, 2019-2026, $ mn 75
Table 14. Germany Human Insulin Market by Product Type, 2019-2026, $ mn 77
Table 15. Germany Human Insulin Market by Application, 2019-2026, $ mn 77
Table 16. Germany Human Insulin Market by Distribution Channel, 2019-2026, $ mn 77
Table 17. UK Human Insulin Market by Product Type, 2019-2026, $ mn 79
Table 18. UK Human Insulin Market by Application, 2019-2026, $ mn 79
Table 19. UK Human Insulin Market by Distribution Channel, 2019-2026, $ mn 79
Table 20. France Human Insulin Market by Product Type, 2019-2026, $ mn 81
Table 21. France Human Insulin Market by Application, 2019-2026, $ mn 81
Table 22. France Human Insulin Market by Distribution Channel, 2019-2026, $ mn 81
Table 23. Spain Human Insulin Market by Product Type, 2019-2026, $ mn 83
Table 24. Spain Human Insulin Market by Application, 2019-2026, $ mn 83
Table 25. Spain Human Insulin Market by Distribution Channel, 2019-2026, $ mn 83
Table 26. Italy Human Insulin Market by Product Type, 2019-2026, $ mn 85
Table 27. Italy Human Insulin Market by Application, 2019-2026, $ mn 85
Table 28. Italy Human Insulin Market by Distribution Channel, 2019-2026, $ mn 85
Table 29. Human Insulin Market in Rest of Europe by Country, 2019-2026, $ mn 87
Table 30. Europe Human Insulin Market by Key Vendor, 2019, $ mn 90
Table 31. Astra Zeneca PLC: Company Snapshot 94
Table 32. Astra Zeneca PLC: Business Segmentation 94
Table 33. Astra Zeneca PLC: Product Portfolio 95
Table 34. Astra Zeneca PLC: Revenue, 2016-2018, $ mn 95
Table 35. Astra Zeneca PLC: Recent Developments 95
Table 36. Risk Evaluation for Investing in Europe Market, 2019-2026 106
Table 37. Critical Success Factors and Key Takeaways 109

List of Figures

Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 15
Figure 4. Europe Human Insulin Market, 2019-2026, $ mn 17
Figure 5. Primary Drivers and Impact Factors of Europe Human Insulin Market 18
Figure 6. Primary Restraints and Impact Factors of Europe Human Insulin Market 21
Figure 7. Porter's Fiver Forces Analysis of Europe Human Insulin Market 27
Figure 8. Breakdown of Europe Human Insulin Market by Product Type, 2019-2026, % of Revenue 31
Figure 9. Contribution to Europe 2020-2026 Cumulative Revenue by Product Type, Value ($ mn) and Share (%) 32
Figure 10. Europe Human Insulin Market: Human Insulin Drugs, 2019-2026, $ mn 33
Figure 11. Europe Human Insulin Market: Human Insulin Delivery Devices, 2019-2026, $ mn 34
Figure 12. Breakdown of Europe Human Insulin Drugs Market by Product, 2019-2026, % of Revenue 35
Figure 13. Contribution to Europe Human Insulin Drugs Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%) 36
Figure 14. Europe Human Insulin Market: Modern Human Insulin, 2019-2026, $ mn 37
Figure 15. Europe Modern Human Insulin Market: Long-acting, 2019-2026, $ mn 39
Figure 16. Europe Modern Human Insulin Market: Rapid- acting, 2019-2026, $ mn 40
Figure 17. Europe Modern Human Insulin Market: Premixed, 2019-2026, $ mn 41
Figure 18. Europe Modern Human Insulin Market: Lantus, 2019-2026, $ mn 42
Figure 19. Europe Modern Human Insulin Market: Apidra, 2019-2026, $ mn 43
Figure 20. Europe Modern Human Insulin Market: Levemir, 2019-2026, $ mn 44
Figure 21. Europe Modern Human Insulin Market: NovoRapid/ NovoLog, 2019-2026, $ mn 45
Figure 22. Europe Modern Human Insulin Market: Novomix, 2019-2026, $ mn 46
Figure 23. Europe Modern Human Insulin Market: Humalog, 2019-2026, $ mn 47
Figure 24. Europe Modern Human Insulin Market: Other Brands, 2019-2026, $ mn 48
Figure 25. Europe Human Insulin Market: Traditional Human Insulin, 2019-2026, $ mn 49
Figure 26. Europe Traditional Human Insulin Market: Short-acting, 2019-2026, $ mn 51
Figure 27. Europe Traditional Human Insulin Market: Intermediate & Rapid-acting, 2019-2026, $ mn 52
Figure 28. Europe Traditional Human Insulin Market: Premixed, 2019-2026, $ mn 53
Figure 29. Europe Traditional Human Insulin Market: Humulin, 2019-2026, $ mn 54
Figure 30. Europe Traditional Human Insulin Market: Insuman, 2019-2026, $ mn 55
Figure 31. Europe Traditional Human Insulin Market: Novolin/Actrapid/Insulatard, 2019-2026, $ mn 56
Figure 32. Breakdown of Europe Human Insulin Delivery Devices Market by Product, 2019-2026, % of Revenue 57
Figure 33. Contribution to Europe Human Insulin Delivery Devices Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%) 58
Figure 34. Europe Human Insulin Delivery Devices Market: Syringes, 2019-2026, $ mn 59
Figure 35. Europe Human Insulin Delivery Devices Market: Pens, 2019-2026, $ mn 60
Figure 36. Europe Human Insulin Delivery Devices Market: Pumps, 2019-2026, $ mn 61
Figure 37. Europe Human Insulin Delivery Devices Market: Other Devices, 2019-2026, $ mn 62
Figure 38. Breakdown of Europe Human Insulin Market by Application, 2019-2026, % of Revenue 63
Figure 39. Contribution to Europe 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%) 64
Figure 40. Europe Human Insulin Market: Type 1 Diabetes, 2019-2026, $ mn 65
Figure 41. Europe Human Insulin Market: Type 2 Diabetes, 2019-2026, $ mn 66
Figure 42. Europe Human Insulin Market: Gestational Diabetes and Prediabetes, 2019-2026, $ mn 67
Figure 43. Breakdown of Europe Human Insulin Market by Distribution Channel, 2019-2026, % of Revenue 68
Figure 44. Contribution to Europe 2020-2026 Cumulative Revenue by Distribution Channel, Value ($ mn) and Share (%) 69
Figure 45. Europe Human Insulin Market: Hospital Pharmacies, 2019-2026, $ mn 70
Figure 46. Europe Human Insulin Market: Retail Pharmacies, 2019-2026, $ mn 71
Figure 47. Europe Human Insulin Market: Online Pharmacies, 2019-2026, $ mn 72
Figure 48. Breakdown of European Human Insulin Market by Country, 2019 and 2026, % of Revenue 74
Figure 49. Contribution to Europe 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 75
Figure 50. Human Insulin Market in Germany, 2019-2026, $ mn 76
Figure 51. Human Insulin Market in UK, 2019-2026, $ mn 78
Figure 52. Human Insulin Market in France, 2019-2026, $ mn 80
Figure 53. Human Insulin Market in Spain, 2019-2026, $ mn 82
Figure 54. Human Insulin Market in Italy, 2019-2026, $ mn 84
Figure 55. Human Insulin Market in Rest of Europe, 2019-2026, $ mn 86
Figure 56. Growth Stage of Europe Human Insulin Industry over the Forecast Period 88
  • (COVID-19 Version) Global Metformin Hydrochloride Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 22-Oct-2020        Price: US 3000 Onwards        Pages: 90
    Summary The report forecast global Metformin Hydrochloride market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Metformin Hydrochloride industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Metformin Hydrochlor......
  • Global Antidiabetic Biguanides Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 22-Oct-2020        Price: US 3400 Onwards        Pages: 119
    The Antidiabetic Biguanides market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Antidiabetic Biguanides market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Antidiabetic Biguanides market. The report focuses on well-known providers in the global Antidiabetic Biguanides industry, market segments, ......
  • Global Diabetic Therapeutic Drugs Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 22-Oct-2020        Price: US 3400 Onwards        Pages: 124
    The Diabetic Therapeutic Drugs market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Diabetic Therapeutic Drugs market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Diabetic Therapeutic Drugs market. The report focuses on well-known providers in the global Diabetic Therapeutic Drugs industry, marke......
  • Global Antidiabetic Thiazolidinediones Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 129
    The Antidiabetic Thiazolidinediones market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Antidiabetic Thiazolidinediones market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Antidiabetic Thiazolidinediones market. The report focuses on well-known providers in the global Antidiabetic Thiazolidinedi......
  • Global Liraglutide Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 13-Oct-2020        Price: US 3400 Onwards        Pages: 119
    The Liraglutide market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Liraglutide market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Liraglutide market. The report focuses on well-known providers in the global Liraglutide industry, market segments, competition, and the macro environment. ......
  • Global Acarbose Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 13-Oct-2020        Price: US 3400 Onwards        Pages: 115
    The Acarbose market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Acarbose market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Acarbose market. The report focuses on well-known providers in the global Acarbose industry, market segments, competition, and the macro environment. Under......
  • COVID-19 World Insulin API Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 08-Oct-2020        Price: US 2800 Onwards        Pages: 92
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Insulin API , covering Global total and ......
  • Global Human Insulin Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 08-Oct-2020        Price: US 3400 Onwards        Pages: 124
    The Human Insulin market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Human Insulin market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Human Insulin market. The report focuses on well-known providers in the global Human Insulin industry, market segments, competition, and the macro environment.......
  • (COVID-19 Version) Global Lixisenatide Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 07-Oct-2020        Price: US 3000 Onwards        Pages: 95
    Summary The report forecast global Lixisenatide market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Lixisenatide industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Lixisenatide by geography. The report spli......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs